![]() CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. | ![]() Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | Elixiron Immunotherapeutics Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases. | ![]() Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | |
Founding Date | Founding Date 1983 | Founding Date 2000 | Founding Date 2017 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Vienna, US HQ | Locations Lund, SE HQ | Locations TW HQ | Locations Hamburg, DE HQ Bremen, DE |
Employees | Employees N/A | Employees 950% increase | Employees 19 | Employees N/A |
Financial | ||||
Net income | Net income ($25.4m) (FY, 2025) | Net income (kr90m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 27m (almost 5 years ago) | Latest funding round $ 5m (over 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 10.8m | Total funding raised $ 37.5m | Total funding raised $ 20.8m |

Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View companyElixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases.
View company
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company